Bashir is a Council member appointed by the Senate in 2015. An academic haematologist by profession, he is currently Associate Professor in the Faculty of Health Sciences. He has studied or worked in four academic institutions in the UK, the last 24 years continuously in the University of Southampton. He gained his PhD in 1998 from the Faculty of Medicine at Southampton and was awarded the Fellowship of the Royal College of Pathologists (FRCPath) in 2008.
With a wide ranging international expertise and experience in clinical academia and healthcare environments he is member of several professional and learned societies. He is a Fellow of the Institute of Biomedical Sciences, a Chartered Biologist and Fellow of the Society of Biologist, a Member of the British Society for Haematology and the British Society of Haemostasis and Thrombosis. He has also served on a number of national education and professional bodies, representing Faculty and University helping to shape national agendas on education, training and curriculum development. This includes Modernising Scientific Careers Programmes and Council of Healthcare Science in Higher Education, Registration Council for Clinical Physiologists, Association for Clinical Physiology Education and the British Society for Haematology Science Sub-committee. He served on the Faculty of Health Sciences Board and currently sits on the Thrombosis Committee, Southampton University Hospitals as well as the Wessex Medical Research Scientific Advisory Committee.
He has a keen interest in and is passionate about The University’s international agenda. Recently he has been very active in promoting formal internationalisation agreements, working closely with the International Office. He is also an entrepreneurial academic; in addition to holding IP rights, he works in an advisory capacity with commercial organisations both in Europe and North America.
Bashir has developed and sustained major research activities of international reputation in fields as diverse as diagnostic haematology and cancer therapy. His work has always aspired to clinical translation through influencing evidence-based practice or commercial product development; recent research findings have featured at BBC-Online. He has served on editorial boards of over fifteen journals and has been an Editor for four peer-reviewed international journals.